Toshimichi Ueda
Director/Board Member at SIGNPOST CORPORATION
Profile
Toshimichi Ueda is currently the Director & External Auditor at SanBio, Inc. He also holds the position of Director & Vice President at Hibiki Partners Co., Ltd.
since 2012 and Independent Outside Director at Signpost Corp.
(Tokyo) since 2018.
He completed his undergraduate degree from Keio University.
Toshimichi Ueda active positions
| Companies | Position | Start |
|---|---|---|
| SIGNPOST CORPORATION | Director/Board Member | 2018-05-29 |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Director/Board Member | - |
| Hibiki Partners Co., Ltd. | Director/Board Member | 2012-08-31 |
Training of Toshimichi Ueda
| Keio University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SIGNPOST CORPORATION | Health Services |
| Private companies | 2 |
|---|---|
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
| Hibiki Partners Co., Ltd. |
- Stock Market
- Insiders
- Toshimichi Ueda
